Showing 1 - 1 results of 1 for search '"Multiple myeloma. Bortezomib. Thalidomide. Acute phase response. Survival."', query time: 0.06s Refine Results
  1. 1
    Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study

    Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study by Juan M. Cano-Calderón, Juan F. Zazueta-Pozos, Adán G. Gallardo-Rodríguez, Carlos Martínez-Murillo, Irma Olarte-Carrillo, Adolfo Martínez-Tovar, Christian O. Ramos-Peñafiel

    Published 2025-01-01
    Subjects: “…Multiple myeloma. Bortezomib. Thalidomide. Acute phase response. Survival.…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: